Opendata, web and dolomites

PATH-TOX SIGNED

Artificial Intelligence to transform Drug and Chemical safety testing

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PATH-TOX project word cloud

Explore the words cloud of the PATH-TOX project. It provides you a very rough idea of what is the project "PATH-TOX" about.

patholytix    pathological    manually    pathology    diagnostic    compare    markets    lack    tissue    normal    data    discovery    aided    performance    artificial    ai    thousands    reducing    trained    purpose    animal    looming    direct    competitors    date    intelligence    expensive    automatically    framework    individual    perform    pharmaceuticals    pharma    engine    janssen    solutions    drugs    sections    components    led    tests    risky    upfront    optimise    competition    workflow    fit    review    hence    effect    consuming    drug    irish    accelerate    manual    time    veterinary    sme    once    routinely    abnormal    crisis    expand    global    validation    swiss    worldwide    image    mainly    big    tox    deciphex    knock    computer    liver    regards    cros    pathologist    safety    ltd    customers    belgium    tissues    yields    tools    pathologists    interface    undergo    streamline    cloud    toxicology    market    toxicity    prototype    animals    benchmarking   

Project "PATH-TOX" data sheet

The following table provides information about the project.

Coordinator
JANSSEN PHARMACEUTICA NV 

Organization address
address: TURNHOUTSEWEG 30
city: BEERSE
postcode: 2340
website: www.janssenpharmaceutica.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 2˙935˙000 €
 EC max contribution 2˙054˙499 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2020-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    JANSSEN PHARMACEUTICA NV BE (BEERSE) coordinator 134˙531.00
2    DECIPHEX LIMITED IE (MORNINGTON MEATH) participant 1˙626˙843.00
3    PDS PATHOLOGY DATA SYSTEMS AG CH (PRATTEIN) participant 293˙125.00

Map

 Project objective

Drug discovery is a time consuming, expensive and risky process. Each drug to market must undergo safety/ toxicity testing in animals which yields thousands of tissue sections that currently must be assessed manually by a trained veterinary pathology. However, there is a looming crisis due to the lack pathologists.

The PATH-TOX consortium is led by Irish SME, Deciphex Ltd, and includes key partners such as Janssen Pharmaceuticals in Belgium and Pathology Data Systems Ltd a Swiss based SME. They are creating PATHOLYTIX-TOX a computer aided diagnostic system to streamline the pathology review process. Using state-of-the-art artificial intelligence (AI) image analysis tools it will automatically identify the normal and abnormal tissues upfront, allowing the pathologist to focus mainly on the abnormal cases, hence accelerate workflow.

To date, we have built a working prototype of the image analysis engine, which can identify abnormal tissue in liver. In this project we will optimise the engine further to improve performance and expand its use into other tissues. We will also develop other features such as the user interface, data management and cloud framework. Once developed, we will perform a comprehensive validation and benchmarking study to compare to manual pathology assessment.

There is a large, growing, global target market for PATHOLYTIX-TOX. Pharma and CROs worldwide routinely perform thousands of animal toxicology tests each year, who are potential customers. With regards to competitors, there is no direct competition. Competitors offer individual components of the pathological workflow, not fit-for-purpose solutions for the toxicology pathology market.

Overall, PATHOLYTIX would have a big impact on drug development, by reducing the time required for pathology review and associated costs. This should have a knock on effect for the global and EU markets, reducing time and cost for new drugs to get to market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PATH-TOX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PATH-TOX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

Bio-LP-1 (2020)

A novel rapid environmental test for the human pathogen Legionella

Read More  

GoSafe (2019)

Restoring complete sensory ability for natural walking of amputees

Read More  

SAMBAfun (2018)

System for AcceleroMeter-Based Assessment of cardiac FUNction

Read More